{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T22:26:36Z","timestamp":1784154396020,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-024-01816-2","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T04:27:49Z","timestamp":1726028869000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["TMEM100 acts as a TAK1 receptor that prevents pathological cardiac hypertrophy progression"],"prefix":"10.1186","volume":"22","author":[{"given":"Bin-Bin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Lin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Yu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Xue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Cai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan-Ying","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,11]]},"reference":[{"key":"1816_CR1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990\u20132019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020;76:2982\u20133021. https:\/\/doi.org\/10.1016\/j.jacc.2020.11.010.","journal-title":"J Am Coll Cardiol"},{"key":"1816_CR2","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/cir.0000000000001063","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, et al. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145:e895\u20131032. https:\/\/doi.org\/10.1161\/cir.0000000000001063.","journal-title":"Circulation"},{"key":"1816_CR3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura M, Sadoshima J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol. 2018;15:387\u2013407. https:\/\/doi.org\/10.1038\/s41569-018-0007-y.","journal-title":"Nat Rev Cardiol"},{"key":"1816_CR4","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41569-022-00806-6","volume":"20","author":"TG Martin","year":"2023","unstructured":"Martin TG, Juarros MA, Leinwand LA. Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential. Nat Rev Cardiol. 2023;20:347\u201363. https:\/\/doi.org\/10.1038\/s41569-022-00806-6.","journal-title":"Nat Rev Cardiol"},{"key":"1816_CR5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s10456-020-09713-1","volume":"23","author":"EH Moon","year":"2020","unstructured":"Moon EH, et al. TMEM100 is a key factor for specification of lymphatic endothelial progenitors. Angiogenesis. 2020;23:339\u201355. https:\/\/doi.org\/10.1007\/s10456-020-09713-1.","journal-title":"Angiogenesis"},{"key":"1816_CR6","doi-asserted-by":"publisher","first-page":"12064","DOI":"10.1073\/pnas.1207210109","volume":"109","author":"S Somekawa","year":"2012","unstructured":"Somekawa S, et al. Tmem100, an ALK1 receptor signaling-dependent gene essential for arterial endothelium differentiation and vascular morphogenesis. Proc Natl Acad Sci U S A. 2012;109:12064\u20139. https:\/\/doi.org\/10.1073\/pnas.1207210109.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1816_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.toxlet.2018.12.010","volume":"317","author":"LX Pan","year":"2019","unstructured":"Pan LX, et al. TMEM100 mediates inflammatory cytokines secretion in hepatic stellate cells and its mechanism research. Toxicol Lett. 2019;317:82\u201391. https:\/\/doi.org\/10.1016\/j.toxlet.2018.12.010.","journal-title":"Toxicol Lett"},{"key":"1816_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.899385","volume":"12","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, Zhao Y, Jiang J, Zou B, Dong L. Transmembrane Protein 100 Inhibits the Progression of Colorectal Cancer by Promoting the Ubiquitin\/Proteasome Degradation of HIF-1\u03b1. Front Oncol. 2022;12:899385. https:\/\/doi.org\/10.3389\/fonc.2022.899385.","journal-title":"Front Oncol"},{"key":"1816_CR9","doi-asserted-by":"publisher","unstructured":"He Q, et al. TMEM100 induces cell death in non\u2011small cell lung cancer via the activation of autophagy and apoptosis. Oncol Rep. 2021;45.\u00a0https:\/\/doi.org\/10.3892\/or.2021.8014.","DOI":"10.3892\/or.2021.8014"},{"key":"1816_CR10","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.neuron.2014.12.065","volume":"85","author":"HJ Weng","year":"2015","unstructured":"Weng HJ, et al. Tmem100 Is a Regulator of TRPA1-TRPV1 Complex and Contributes to Persistent Pain. Neuron. 2015;85:833\u201346. https:\/\/doi.org\/10.1016\/j.neuron.2014.12.065.","journal-title":"Neuron"},{"key":"1816_CR11","doi-asserted-by":"publisher","unstructured":"Ma J, et al. TMEM100 negatively regulated by microRNA\u2011106b facilitates cellular apoptosis by suppressing survivin expression in NSCLC. Oncol Rep. 2021;46. https:\/\/doi.org\/10.3892\/or.2021.8136","DOI":"10.3892\/or.2021.8136"},{"key":"1816_CR12","doi-asserted-by":"publisher","unstructured":"Mizuta K, et al. TMEM100: A Novel Intracellular Transmembrane Protein Essential for Vascular Development and Cardiac Morphogenesis. In: Nakanishi, et al., editors. Etiology and Morphogenesis of Congenital Heart Disease. Tokyo: Springer; 2016.\u00a0Chapter 21. https:\/\/doi.org\/10.1007\/978-4-431-54628-3_21.","DOI":"10.1007\/978-4-431-54628-3_21"},{"key":"1816_CR13","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1161\/circresaha.121.318866","volume":"130","author":"J Liu","year":"2022","unstructured":"Liu J, et al. The E3 Ligase TRIM16 Is a Key Suppressor of Pathological Cardiac Hypertrophy. Circ Res. 2022;130:1586\u2013600. https:\/\/doi.org\/10.1161\/circresaha.121.318866.","journal-title":"Circ Res"},{"key":"1816_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1161\/circulationaha.119.042178","volume":"141","author":"S Chen","year":"2020","unstructured":"Chen S, et al. A Novel Role of Cyclic Nucleotide Phosphodiesterase 10A in Pathological Cardiac Remodeling and Dysfunction. Circulation. 2020;141:217\u201333. https:\/\/doi.org\/10.1161\/circulationaha.119.042178.","journal-title":"Circulation"},{"key":"1816_CR15","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/j.cmet.2021.08.014","volume":"33","author":"XJ Zhang","year":"2021","unstructured":"Zhang XJ, et al. Pharmacological inhibition of arachidonate 12-lipoxygenase ameliorates myocardial ischemia-reperfusion injury in multiple species. Cell Metab. 2021;33:2059-2075.e2010. https:\/\/doi.org\/10.1016\/j.cmet.2021.08.014.","journal-title":"Cell Metab"},{"key":"1816_CR16","doi-asserted-by":"publisher","unstructured":"Gu Y, Yao YR, Ding Y, Zhang XW. Reduced expression of transmembrane protein 43 during cardiac hypertrophy leads to worsening heart failure in mice. Exp Biol Med (Maywood). 2023. https:\/\/doi.org\/10.1177\/15353702231191111.","DOI":"10.1177\/15353702231191111"},{"key":"1816_CR17","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s00018-022-04458-0","volume":"79","author":"N Klinke","year":"2022","unstructured":"Klinke N, et al. A Drosophila melanogaster model for TMEM43-related arrhythmogenic right ventricular cardiomyopathy type 5. Cell Mol Life Sci. 2022;79:444. https:\/\/doi.org\/10.1007\/s00018-022-04458-0.","journal-title":"Cell Mol Life Sci"},{"key":"1816_CR18","doi-asserted-by":"publisher","unstructured":"Chen Z, et al. TMEM43 Protects against Sepsis-Induced Cardiac Injury via Inhibiting Ferroptosis in Mice. Cells. 2022;11. https:\/\/doi.org\/10.3390\/cells11192992.","DOI":"10.3390\/cells11192992"},{"key":"1816_CR19","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1038\/s41440-023-01377-w","volume":"46","author":"Y Yang","year":"2023","unstructured":"Yang Y, et al. Transmembrane protein 117 knockdown protects against angiotensin-II-induced cardiac hypertrophy. Hypertens Res. 2023;46:2326\u201339. https:\/\/doi.org\/10.1038\/s41440-023-01377-w.","journal-title":"Hypertens Res"},{"key":"1816_CR20","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3724\/abbs.2022180","volume":"55","author":"C Pan","year":"2022","unstructured":"Pan C, et al. Upregulation of DRG protein TMEM100 facilitates dry-skin-induced pruritus by enhancing TRPA1 channel function. Acta Biochim Biophys Sin (Shanghai). 2022;55:404\u201316. https:\/\/doi.org\/10.3724\/abbs.2022180.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"1816_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1515\/hsz-2019-0161","volume":"401","author":"J Zhuang","year":"2020","unstructured":"Zhuang J, et al. TMEM100 expression suppresses metastasis and enhances sensitivity to chemotherapy in gastric cancer. Biol Chem. 2020;401:285\u201396. https:\/\/doi.org\/10.1515\/hsz-2019-0161.","journal-title":"Biol Chem"},{"key":"1816_CR22","doi-asserted-by":"publisher","first-page":"17379","DOI":"10.18632\/oncotarget.3954","volume":"6","author":"D Ou","year":"2015","unstructured":"Ou D, Yang H, Hua D, Xiao S, Yang L. Novel roles of TMEM100: inhibition metastasis and proliferation of hepatocellular carcinoma. Oncotarget. 2015;6:17379\u201390. https:\/\/doi.org\/10.18632\/oncotarget.3954.","journal-title":"Oncotarget"},{"key":"1816_CR23","doi-asserted-by":"publisher","first-page":"7972","DOI":"10.1080\/21655979.2021.2018979","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu J, Lin F, Wang X, Li C, Qi Q. GATA binding protein 5-mediated transcriptional activation of transmembrane protein 100 suppresses cell proliferation, migration and epithelial-to-mesenchymal transition in prostate cancer DU145 cells. Bioengineered. 2022;13:7972\u201383. https:\/\/doi.org\/10.1080\/21655979.2021.2018979.","journal-title":"Bioengineered"},{"key":"1816_CR24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13073-018-0601-y","volume":"10","author":"EK H\u00f6glander","year":"2018","unstructured":"H\u00f6glander EK, et al. Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations. Genome Med. 2018;10:92. https:\/\/doi.org\/10.1186\/s13073-018-0601-y.","journal-title":"Genome Med"},{"key":"1816_CR25","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1161\/circulationaha.120.050812","volume":"143","author":"H Yu","year":"2021","unstructured":"Yu H, et al. LARP7 Protects Against Heart Failure by Enhancing Mitochondrial Biogenesis. Circulation. 2021;143:2007\u201322. https:\/\/doi.org\/10.1161\/circulationaha.120.050812.","journal-title":"Circulation"},{"key":"1816_CR26","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.freeradbiomed.2023.10.395","volume":"209","author":"S Guo","year":"2023","unstructured":"Guo S, et al. RNF13 protects against pathological cardiac hypertrophy through p62-NRF2 pathway. Free Radic Biol Med. 2023;209:252\u201364. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.10.395.","journal-title":"Free Radic Biol Med"},{"key":"1816_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1161\/circulationaha.120.052384","volume":"144","author":"Y Luo","year":"2021","unstructured":"Luo Y, et al. Cooperative Binding of ETS2 and NFAT Links Erk1\/2 and Calcineurin Signaling in the Pathogenesis of Cardiac Hypertrophy. Circulation. 2021;144:34\u201351. https:\/\/doi.org\/10.1161\/circulationaha.120.052384.","journal-title":"Circulation"},{"key":"1816_CR28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/cvr\/cvac039","volume":"119","author":"L Yuan","year":"2023","unstructured":"Yuan L, et al. RNF207 exacerbates pathological cardiac hypertrophy via post-translational modification of TAB1. Cardiovasc Res. 2023;119:183\u201394. https:\/\/doi.org\/10.1093\/cvr\/cvac039.","journal-title":"Cardiovasc Res"},{"key":"1816_CR29","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1002\/hep.32202","volume":"75","author":"J Zhou","year":"2022","unstructured":"Zhou J, et al. N-acetylgalactosaminyltransferase-4 protects against hepatic ischemia\/reperfusion injury by blocking apoptosis signal-regulating kinase 1 N-terminal dimerization. Hepatology. 2022;75:1446\u201360. https:\/\/doi.org\/10.1002\/hep.32202.","journal-title":"Hepatology"},{"key":"1816_CR30","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s10456-021-09787-5","volume":"24","author":"L Zhu","year":"2021","unstructured":"Zhu L, et al. TAK1 signaling is a potential therapeutic target for pathological angiogenesis. Angiogenesis. 2021;24:453\u201370. https:\/\/doi.org\/10.1007\/s10456-021-09787-5.","journal-title":"Angiogenesis"},{"key":"1816_CR31","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.cmet.2021.05.019","volume":"33","author":"L Wang","year":"2021","unstructured":"Wang L, et al. Tripartite motif 16 ameliorates nonalcoholic steatohepatitis by promoting the degradation of phospho-TAK1. Cell Metab. 2021;33:1372-1388.e1377. https:\/\/doi.org\/10.1016\/j.cmet.2021.05.019.","journal-title":"Cell Metab"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-01816-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-024-01816-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-01816-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T04:31:53Z","timestamp":1726029113000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-024-01816-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,11]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1816"],"URL":"https:\/\/doi.org\/10.1186\/s12964-024-01816-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4361745\/v1","asserted-by":"object"}]},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,11]]},"assertion":[{"value":"3 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments are carried out according to the Guide for the Care and Use of Laboratory Animals, and approved by the Animal Care and Use Committee of the First Affiliated Hospital of Zhengzhou University.Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All of the authors participated in the study and have agreed to the content of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"438"}}